Abstract
Japan is subject to frequent natural disasters. In patients with respiratory diseases, continuous treatment is needed from the acute phase through the chronic phase of a disaster. When a disaster is divided into the acute, subacute, and chronic phases, medication shortages are expected during the acute phase, which delays the distribution of medications and prevents patients from obtaining enough medications. Given this premise, measures are needed to allow many patients to receive treatment equally during the acute phase. During patient education, medical professionals should encourage patients to stockpile necessary medications to be prepared for the acute phase of a disaster and should provide action plans for patients. During the subacute phase, medication stockpiles start to increase, thereby gradually allowing for the provision of regular treatment to patients. During the chronic phase, many residents tend to live in isolation, and patients need continued support.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kirch L, Luther S, Mucke P et al. WorldRiskReport- Analysis and prospects 2017. Bündnis Entwicklung Hilft. 2017. https://reliefweb.int/report/world/world-risk-report-2017. Accessed 6 Feb 2018
Japan Institute of Country-ology and Engineering. http://www.jice.or.jp/knowledge/japan/commentary12#jump_01. Accessed 6 Feb 2018 (in Japanese)
Early Warning Sub-Committee of the Inter-Ministerial Committee on International Cooperation for Disaster Reduction Government of Japan. Japan’s Natural Disaster Early Warning Systems and International Cooperative Efforts. Cabinet Office, Government of Japan. 2006. http://bousaigojp/kokusai/kyoryoku Accessed 6 Feb 2018 (in Japanese)
Nagamatsu S, Maekawa T, Ujike Y, et al. The earthquake and tsunami—observations by Japanese physicians since the11 March catastrophe. Crit Care. 2011;15:167.
Otani Y, Ando T, Atobe K, et al. Comparison of two larger earthquakes: the 2008 Sichuan Earthquake and the 2011 East Japan Earthquake. Keio J Med. 2012;61:35–9.
Japan Pharmaceutical Association. 2015. http://www.nichiyaku.or.jp/saigai2016/files/sr20160415.pdf#search=%27%E7%81%BD%E5%AE%B3%E3%80%81%E8%96%AC%E5%89%A4%E5%82%99%E8%93%84%27. Accessed 6 Feb 2018 (in Japanese)
Fukuhara A, Sato S, Uematsu M, et al. Impact of the 3.11 Disaster in Fukushima on Asthma Control. Am J Respir Crit Care Med. 2012;186:1309–10.
Kobayashi S, Hanagama M, Yamanda S, Satoh H, Tokuda S, Kobayashi M, Ueda S, Suzuki S, Yanai M. The impact of a large-scale natural disaster on patients with chronic obstructive pulmonary disease: the aftermath of the 2011 Great East Japan Earthquake. Respir Investig. 2013;51:17–23.
Yamanouchi K. Medical disease learned from the Great East Japan Earthquake-Feature, Treatment and Prevention; 2 Respiratory Diseases. Nippon Naika Gakkai Zasshi. 2014;103:551–6. in Japanese
Ohkochi S, Shibuya R, Yanai M, Nukiwa T. Deterioration in regional health status after the acute phase of a great disaster: respiratory physicians’ experiences of the Great East Japan Earthquake. Respir Investig. 2013;51:50–5.
Ohkouchi S, et al. Fatal acute interstitial pneumonia a worker making chips from wooden debris generated by the Great East Japan earthquake and tsunami. Respir Investig. 2012;50(4):129.
Japan Pharmaceutical Wholesalers Association. 2015. www.jpwa.or.jp/jpwa/pdf/topics_201601_01.pdf. Accessed 6 Feb 2018 (in Japanese)
Fuse A, Shuto Y, Ando F, et al. Medical relief activities conducted by Nippon Medical School in the acute phase of the Great East Japan Earthquake 2011. J Nihon Med Sch. 2011;78:397–400.
Suzuki M, Uwano C, Ohrui T, et al. Shelter-acquired pneumonia after a catastrophic earthquake in Japan. J Am Geriatr Soc. 2011;59:1968–70.
Koudio IK, Alunid S, Kamigaki T, et al. Infectious diseases following natural disasters: prevention and control measures. Expert Rev Anti-Infect Ther. 2012;10:95–104.
Aghababian RV, Teuacher J. Infectious diseases following major disasters. Ann Emergency Med. 1992;21:362–7.
Mikasa K, Aoki N, Aoki Y, et al. Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy—The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG. J Infect Chemotherapy. 2016;22:S1–S65.
Yokohama Pharmaceutical Association. http://www.hamayaku.or.jp/saigai-2016-5.html. Accessed 6 Feb 2018 (in Japanese)
Oita Pharmaceutical Association. http://www.oitakenyaku.or.jp/manage/wp-content/uploads/2014/09/Mobile-Pharmacy.pdf. Accessed 6 Feb 2018 (in Japanese)
Adachi Y, Fujiwara T. Dealing with asthma/allergy ailments in children during a disaster: a report on the Great East Japan Earthquake and proposals for future actions—5. Countermeasure pamphlet (2) Asthma. Jpn J Pediatr Allergy Clin Immunol. 2011;25:742–5.
Matsui T. Dealing with asthma/allergy ailments in children during a disaster: a report on the Great East Japan Earthquake and proposals for future actions—4. Local assistance. Jpn J Pediatr Allergy Clin Immunol. 2011;25:734–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Komase, Y., Tsuburai, T., Hida, N. (2019). Aggravation of the Existing Respiratory Diseases by the Loss or Difficulty in Supplying of Medicines and Medical Application: What Happened and What Measurements Should the Community and the Patient and His Family Do When the Medicines for the Existing Respiratory Disease Are Lost or Not Supplied?. In: Fujimoto, K. (eds) Disaster and Respiratory Diseases. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-13-2598-4_9
Download citation
DOI: https://doi.org/10.1007/978-981-13-2598-4_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2597-7
Online ISBN: 978-981-13-2598-4
eBook Packages: MedicineMedicine (R0)